Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-25 @ 9:25 PM
Study NCT ID:
NCT00105456
Status:
COMPLETED
Last Update Posted:
2010-05-06
First Post:
2005-03-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
Genentech, Inc.
Organization:
Study Overview
Official Title:
registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer
Status:
COMPLETED
Status Verified Date:
2010-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER2-positive metastatic breast cancer.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: